Drug-related deaths in a university central hospital

被引:101
作者
Juntti-Patinen, L [1 ]
Neuvonen, PJ [1 ]
机构
[1] Univ Helsinki, Cent Hosp, Dept Clin Pharmacol, Helsinki 00029, Finland
关键词
adverse drug reaction; drug-related death; antineoplastic agents; anticoagulants;
D O I
10.1007/s00228-002-0501-2
中图分类号
R9 [药学];
学科分类号
1007 [药学];
摘要
Objectives: The objectives were to determine the incidence of drug-related deaths in a university hospital and to find out which drugs are most commonly involved in these cases. Methods: The files of 1511 death cases (97.7% of all death cases in the Helsinki University Central Hospital during the year,2000) were scrutinised. In the cases of suspected drug-related deaths excluding suicides, the medication, its duration and indications, the route of drug administration, and the type of the adverse reactions were determined. The probability of a fatal adverse drug reaction was classified according to WHO's classification. In addition, the incidence of drug-related deaths was calculated from the death certificates. Results: Scrutiny of the patients' files showed that 75 of the death cases (5.0% of all deaths) were certainly or probably drug-related. This corresponds to about 0.05% of all hospital. admissions. The most common adverse reactions were neutropenia caused by antineoplastic agents and gastrointestinal or intracranial haemorrhage due to anticoagulants or nonsteroidal anti-inflammatory drugs (NSAIDs). The incidence of drug-related deaths is only 0.5% when based on the International Classification of Diseases (ICD) codes in death certificates. Conclusions: Adverse drug reaction is a significant cause of death. Most of the deaths occurred in seriously ill patients with high-risk medication and they are seldom preventable. Incidence figures based on death certificates only may seriously underestimate the true incidence of fatal adverse reactions.
引用
收藏
页码:479 / 482
页数:4
相关论文
共 20 条
[1]
DRUG-ASSOCIATED DEATHS OF MEDICAL INPATIENTS [J].
CARANASOS, GJ ;
MAY, FE ;
STEWART, RB ;
CLUFF, LE .
ARCHIVES OF INTERNAL MEDICINE, 1976, 136 (08) :872-875
[3]
Drug-related illness in emergency department patients [J].
Dennehy, CE ;
Kishi, DT ;
Louie, C .
AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY, 1996, 53 (12) :1422-1426
[4]
Drug-related deaths in a department of internal medicine [J].
Ebbesen, J ;
Buajordet, I ;
Erikssen, J ;
Brors, O ;
Hilberg, T ;
Svaar, H ;
Sandvik, L .
ARCHIVES OF INTERNAL MEDICINE, 2001, 161 (19) :2317-2323
[5]
DRUG-RELATED HOSPITAL ADMISSIONS [J].
EINARSON, TR .
ANNALS OF PHARMACOTHERAPY, 1993, 27 (7-8) :832-840
[6]
Epidemiology of drug exposure and adverse drug reactions in two Swiss departments of internal medicine [J].
Fattinger, K ;
Roos, M ;
Vergères, P ;
Holenstein, C ;
Kind, B ;
Masche, U ;
Stocker, DN ;
Braunschweig, S ;
Kullak-Ublick, GA ;
Galeazzi, RL ;
Follath, F ;
Gasser, T ;
Meier, PJ .
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 2000, 49 (02) :158-167
[7]
HAZARDS, RISKS AND REALITY [J].
FERNER, RE .
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 1992, 33 (02) :125-128
[8]
ADVERSE DRUG-REACTIONS LEADING TO HOSPITAL ADMISSION [J].
IBANEZ, L ;
LAPORTE, JR ;
CARNE, X .
DRUG SAFETY, 1991, 6 (06) :450-459
[9]
DRUG-RELATED ADMISSIONS TO A FAMILY MEDICINE INPATIENT SERVICE [J].
IVES, TJ ;
BENTZ, EJ ;
GWYTHER, RE .
ARCHIVES OF INTERNAL MEDICINE, 1987, 147 (06) :1117-1120
[10]
Potential risks and prevention, part 1: Fatal adverse drug events [J].
Kelly, WN .
AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY, 2001, 58 (14) :1317-1324